Cargando…
Erratum: Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers
Autor principal: | Frontiers Production Office |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178203/ https://www.ncbi.nlm.nih.gov/pubmed/35694261 http://dx.doi.org/10.3389/fphar.2022.931882 |
Ejemplares similares
-
Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers
por: He, Luying, et al.
Publicado: (2022) -
Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab
por: Frontiers Production Office,
Publicado: (2022) -
Rhizoma Coptidis: A Potential Cardiovascular Protective Agent
por: Tan, Hui-Li, et al.
Publicado: (2016) -
Erratum: Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence
por: Frontiers Production Office,
Publicado: (2022) -
Erratum: Targeted ferroptotic potency of ferrous oxide nanoparticles-diethyldithiocarba mate nanocomplex on the metastatic liver cancer
por: Frontiers Production Office
Publicado: (2023)